|
ZNF320 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.78159947800327E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.18939996635237E-09 |
| Normal-vs-Stage2 |
3.083700E-02 |
| Normal-vs-Stage3 |
2.687400E-01 |
| Normal-vs-Stage4 |
3.797800E-01 |
| Stage1-vs-Stage2 |
3.713600E-01 |
| Stage1-vs-Stage3 |
9.382900E-03 |
| Stage1-vs-Stage4 |
1.190800E-01 |
| Stage2-vs-Stage3 |
1.914000E-01 |
| Stage2-vs-Stage4 |
3.882200E-01 |
| Stage3-vs-Stage4 |
9.001800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.29430000050945E-09 |
| Normal-vs-AfricanAmerican |
6.39949999999834E-05 |
| Normal-vs-Asian |
4.100600E-01 |
| Caucasian-vs-AfricanAmerican |
6.188400E-01 |
| Caucasian-vs-Asian |
2.364800E-01 |
| AfricanAmerican-vs-Asian |
2.786400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.84849921428076E-11 |
| Normal-vs-Female |
9.782700E-04 |
| Male-vs-Female |
4.828300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.363510E-03 |
| Normal-vs-Extreme_Weight |
8.16270000000285E-05 |
| Normal-vs-Obese |
4.65380000003179E-06 |
| Normal-vs-Extreme_Obese |
2.848600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.529200E-01 |
| Normal_Weight-vs-Obese |
3.940200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.553200E-01 |
| Extreme_Weight-vs-Obese |
1.607640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.650600E-01 |
| Obese-vs-Extreme_Obese |
1.169160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.144100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.48550002801551E-09 |
| Normal-vs-Age(61-80Yrs) |
3.62859999825105E-08 |
| Normal-vs-Age(81-100Yrs) |
4.734200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.214300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.068640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.620800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.548400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.205000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.435800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.24344978758018E-13 |
| Normal-VS-Type2 PRCC |
1.554420E-01 |
| Normal-VS-KIRP CIMP |
3.640100E-02 |
| Normal-VS-Unclassified PRCC |
3.389200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.71790034922503E-10 |
| Type1 PRCC-VS-KIRP CIMP |
2.99489988364599E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
6.536600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.282530E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.098900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.74339999997808E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.819600E-04 |
| Normal-vs-N1 |
3.163600E-01 |
| Normal-vs-N2 |
3.163800E-02 |
| N0-vs-N1 |
1.410780E-01 |
| N0-vs-N2 |
2.25640000000027E-05 |
| N1-vs-N2 |
1.984700E-03 |
|
|
